{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:44:29Z","timestamp":1792269869320,"version":"4.4.0"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.dld.2026.10.012","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:03:43Z","timestamp":1792267423000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early bile acid reduction in PFIC: what should it predict?"],"prefix":"10.1016","author":[{"given":"Xiao","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0181-6613","authenticated-orcid":false,"given":"Hanxiu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2026.10.012_bib0001","article-title":"Early predictors of pruritus response in children with PFIC treated with odevixibat","volume":"22","author":"Di Giorgio","year":"2026","journal-title":"Dig Liver Dis"},{"issue":"11","key":"10.1016\/j.dld.2026.10.012_bib0002","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1007\/s12325-022-02262-7","article-title":"Validation of the PRUCISION instruments in pediatric patients with progressive familial intrahepatic cholestasis","volume":"39","author":"Gwaltney","year":"2022","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.dld.2026.10.012_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.gastha.2024.100596","article-title":"Food and Drug Administration approval summary: odevixibat (Bylvay) for the treatment of pruritus with progressive familial intrahepatic cholestasis","volume":"4","author":"Yi","year":"2025","journal-title":"Gastro Hep Adv"},{"issue":"4","key":"10.1016\/j.dld.2026.10.012_bib0004","article-title":"Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasis","volume":"7","author":"Di Giorgio","year":"2025","journal-title":"JHEP Rep"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826009916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826009916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:03:49Z","timestamp":1792267429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865826009916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":4,"alternative-id":["S1590865826009916"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2026.10.012","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early bile acid reduction in PFIC: what should it predict?","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.08.036","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}